TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS

The present invention relates to telmisartan or a pharmaceutically acceptable salt thereof as a medicament for the treatment of elevated urinary protein-to-creatinine ratio (UPC) levels in dogs, wherein the therapeutically effective amount of telmisartan is administered in a daily dosage amount that...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FERREIRA DE MOURA LOURENÇO, Bianca Natália, TRAAS, Anne, Michelle, ERICKSON COLEMAN, Amanda, BROWN, Scott, Alan, CREEVY, Kate, Elizabeth
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FERREIRA DE MOURA LOURENÇO, Bianca Natália
TRAAS, Anne, Michelle
ERICKSON COLEMAN, Amanda
BROWN, Scott, Alan
CREEVY, Kate, Elizabeth
description The present invention relates to telmisartan or a pharmaceutically acceptable salt thereof as a medicament for the treatment of elevated urinary protein-to-creatinine ratio (UPC) levels in dogs, wherein the therapeutically effective amount of telmisartan is administered in a daily dosage amount that is varied over a treatment period.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3996705A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3996705A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3996705A13</originalsourceid><addsrcrecordid>eNrjZLAPcfXx9Qx2DApx9FNw8w9SCPFwVQgJcnUM8XX1C1Hwd1Nw9gjy9_N0VvD2dPFzjVRw8Qx2dQx2VfD0U3Dxdw_mYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGlpZm5gamjobGRCgBACETKd0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS</title><source>esp@cenet</source><creator>FERREIRA DE MOURA LOURENÇO, Bianca Natália ; TRAAS, Anne, Michelle ; ERICKSON COLEMAN, Amanda ; BROWN, Scott, Alan ; CREEVY, Kate, Elizabeth</creator><creatorcontrib>FERREIRA DE MOURA LOURENÇO, Bianca Natália ; TRAAS, Anne, Michelle ; ERICKSON COLEMAN, Amanda ; BROWN, Scott, Alan ; CREEVY, Kate, Elizabeth</creatorcontrib><description>The present invention relates to telmisartan or a pharmaceutically acceptable salt thereof as a medicament for the treatment of elevated urinary protein-to-creatinine ratio (UPC) levels in dogs, wherein the therapeutically effective amount of telmisartan is administered in a daily dosage amount that is varied over a treatment period.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220518&amp;DB=EPODOC&amp;CC=EP&amp;NR=3996705A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220518&amp;DB=EPODOC&amp;CC=EP&amp;NR=3996705A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FERREIRA DE MOURA LOURENÇO, Bianca Natália</creatorcontrib><creatorcontrib>TRAAS, Anne, Michelle</creatorcontrib><creatorcontrib>ERICKSON COLEMAN, Amanda</creatorcontrib><creatorcontrib>BROWN, Scott, Alan</creatorcontrib><creatorcontrib>CREEVY, Kate, Elizabeth</creatorcontrib><title>TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS</title><description>The present invention relates to telmisartan or a pharmaceutically acceptable salt thereof as a medicament for the treatment of elevated urinary protein-to-creatinine ratio (UPC) levels in dogs, wherein the therapeutically effective amount of telmisartan is administered in a daily dosage amount that is varied over a treatment period.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAPcfXx9Qx2DApx9FNw8w9SCPFwVQgJcnUM8XX1C1Hwd1Nw9gjy9_N0VvD2dPFzjVRw8Qx2dQx2VfD0U3Dxdw_mYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGlpZm5gamjobGRCgBACETKd0</recordid><startdate>20220518</startdate><enddate>20220518</enddate><creator>FERREIRA DE MOURA LOURENÇO, Bianca Natália</creator><creator>TRAAS, Anne, Michelle</creator><creator>ERICKSON COLEMAN, Amanda</creator><creator>BROWN, Scott, Alan</creator><creator>CREEVY, Kate, Elizabeth</creator><scope>EVB</scope></search><sort><creationdate>20220518</creationdate><title>TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS</title><author>FERREIRA DE MOURA LOURENÇO, Bianca Natália ; TRAAS, Anne, Michelle ; ERICKSON COLEMAN, Amanda ; BROWN, Scott, Alan ; CREEVY, Kate, Elizabeth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3996705A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FERREIRA DE MOURA LOURENÇO, Bianca Natália</creatorcontrib><creatorcontrib>TRAAS, Anne, Michelle</creatorcontrib><creatorcontrib>ERICKSON COLEMAN, Amanda</creatorcontrib><creatorcontrib>BROWN, Scott, Alan</creatorcontrib><creatorcontrib>CREEVY, Kate, Elizabeth</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FERREIRA DE MOURA LOURENÇO, Bianca Natália</au><au>TRAAS, Anne, Michelle</au><au>ERICKSON COLEMAN, Amanda</au><au>BROWN, Scott, Alan</au><au>CREEVY, Kate, Elizabeth</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS</title><date>2022-05-18</date><risdate>2022</risdate><abstract>The present invention relates to telmisartan or a pharmaceutically acceptable salt thereof as a medicament for the treatment of elevated urinary protein-to-creatinine ratio (UPC) levels in dogs, wherein the therapeutically effective amount of telmisartan is administered in a daily dosage amount that is varied over a treatment period.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3996705A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A05%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FERREIRA%20DE%20MOURA%20LOUREN%C3%87O,%20Bianca%20Nat%C3%A1lia&rft.date=2022-05-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3996705A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true